|
NDE1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.02560182568823E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.16669999947494E-07 |
| Normal-vs-Stage2 |
1.238110E-02 |
| Normal-vs-Stage3 |
6.990400E-04 |
| Normal-vs-Stage4 |
1.901250E-01 |
| Stage1-vs-Stage2 |
8.684200E-01 |
| Stage1-vs-Stage3 |
5.436400E-01 |
| Stage1-vs-Stage4 |
5.294400E-01 |
| Stage2-vs-Stage3 |
5.094800E-01 |
| Stage2-vs-Stage4 |
5.889000E-01 |
| Stage3-vs-Stage4 |
2.986400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.10729980740132E-10 |
| Normal-vs-AfricanAmerican |
6.40499999999822E-05 |
| Normal-vs-Asian |
4.450800E-01 |
| Caucasian-vs-AfricanAmerican |
4.545600E-01 |
| Caucasian-vs-Asian |
4.570400E-01 |
| AfricanAmerican-vs-Asian |
5.758600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.66530000900167E-09 |
| Normal-vs-Female |
2.88510000334696E-08 |
| Male-vs-Female |
7.580200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.993700E-02 |
| Normal-vs-Extreme_Weight |
1.94351999999176E-05 |
| Normal-vs-Obese |
8.4102000030839E-08 |
| Normal-vs-Extreme_Obese |
2.855800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.933900E-02 |
| Normal_Weight-vs-Obese |
7.822600E-04 |
| Normal_Weight-vs-Extreme_Obese |
5.870000E-01 |
| Extreme_Weight-vs-Obese |
1.564010E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.123800E-01 |
| Obese-vs-Extreme_Obese |
2.963400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.264930E-03 |
| Normal-vs-Age(41-60Yrs) |
1.48330236982019E-11 |
| Normal-vs-Age(61-80Yrs) |
1.52274999999369E-05 |
| Normal-vs-Age(81-100Yrs) |
2.098400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.358600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.314400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.897800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.980600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.076100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.762410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.3751447737227E-12 |
| Normal-VS-Type2 PRCC |
2.076300E-02 |
| Normal-VS-KIRP CIMP |
5.699100E-03 |
| Normal-VS-Unclassified PRCC |
6.03449999999617E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.215920E-04 |
| Type1 PRCC-VS-KIRP CIMP |
4.527800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.527800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.064900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.555200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.698200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.180800E-03 |
| Normal-vs-N1 |
2.039300E-03 |
| Normal-vs-N2 |
1.573800E-01 |
| N0-vs-N1 |
9.467500E-02 |
| N0-vs-N2 |
2.699600E-01 |
| N1-vs-N2 |
8.409800E-01 |
|
|
